Literature DB >> 10857741

Seasonal variation in human functional cerebral lateralization and free testosterone concentrations.

A B Wisniewski1, R J Nelson.   

Abstract

Men have previously been reported to exhibit seasonal fluctuations on specific types of cognitive performance. It has been speculated that this performance variability is a result of changes in cerebral asymmetry due to lowered testosterone concentrations in the spring relative to the fall. In the present study, functional cerebral lateralization was measured in a group of men and women in the spring and fall. Free testosterone concentrations were assessed for participants to determine what associations might exist between seasonal variability in lateralization and seasonal fluctuations in testosterone exposure. Men and women tested in the spring exhibited exaggerated patterns of asymmetry compared to participants tested in the fall. Lower testosterone concentrations were observed in the spring compared to the fall in women, but not men. No direct associations between testosterone and lateralization were detected for either sex at either season. These results illustrate that seasonal fluctuations in testosterone exposure do not directly influence seasonal changes in functional lateralization patterns.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10857741

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  2 in total

1.  Seasonal variation of salivary testosterone in men, normally cycling women, and women using hormonal contraceptives.

Authors:  Steven J Stanton; O'Dhaniel A Mullette-Gillman; Scott A Huettel
Journal:  Physiol Behav       Date:  2011-07-23

2.  Exposure of postnatal rats to a static magnetic field of 0.14 T influences functional laterality of the hippocampal high-affinity choline uptake system in adulthood; in vitro test with magnetic nanoparticles.

Authors:  Z Kristofiková; M Cermák; O Benesová; J Klaschka; P Zach
Journal:  Neurochem Res       Date:  2005-02       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.